In order to implement the principal responsibilities of drug marketing authorization holders and pharmacovigilance main body responsibility and guide drug marketing authorization holders to create and maintain master files of pharmacovigilance system, the National Center for ADR Monitoring has formulated the Guidance for the Preparation of Master Files of Pharmacovigilance System in accordance with the requirements of the National Medical Products Administration, which was issued on February 25, 2022.